Page last updated: 2024-11-05

thalidomide and Foot Diseases

thalidomide has been researched along with Foot Diseases in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Foot Diseases: Anatomical and functional disorders affecting the foot.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JAMES, JI1
LAMB, DW1
FRANKLIN, AW1

Other Studies

2 other studies available for thalidomide and Foot Diseases

ArticleYear
CONGENITAL ABNORMALITIES OF THE LIMBS.
    The Practitioner, 1963, Volume: 191

    Topics: Arm; Congenital Abnormalities; Ectromelia; Extremities; Foot Diseases; Hand Deformities; Hip Disloca

1963
THE CHILD WITH CONGENITAL LIMB DEFORMITIES.
    The Practitioner, 1964, Volume: 192

    Topics: Abnormalities, Drug-Induced; Achondroplasia; Arm; Congenital Abnormalities; Ectromelia; Education; F

1964